Applications of CRISPR Technologies in Research and Industry

3/30/2017, 6:30 PM to 8:30 PM | German House New York

Applications of CRISPR Technologies in Research and Industry

Few discoveries have attracted more attention in the area of molecular biology over the last three years than CRISPR-Cas9, a relatively new technology that is groundbreaking, controversial and developing rapidly. Science Magazine featured CRISPR-Cas9 on its cover in 2015, calling it a "breakthrough," and MIT Technology Review called it the "biggest biotech discovery of the century." The technology makes gene editing simple, affordable, and precise. At present, scientists are exploring the potential of CRISPR-Cas9 to cure a host of human diseases. These tools are also being used to expedite crop and livestock breeding, engineer new antimicrobials and control disease-carrying insects.

Our panelists will address a number of the applications of this cutting-edge technology and discuss some of its challenges.

This program is funded in part by a grant from the Delegation of the European Union to the United States.

To RSVP to the event by March 28, please click here.

  • Featured Speakers

    • Dr. Paul Bernasconi

      Director, Molecular Biology; Manager, RTP Plant Science Research Site, BASF

    • Prof. Dr. Branko Zevnik

      Head, in vivo Research Facility, CECAD Cologne

    • Dr. Ghassan Yehia

      Scientific Director, Genome Editing Core Facility, Rutgers, the State University of New Jersey

    • Dr. Benedikt Bosbach (Moderator)

      Researcher, Oncology Target Discovery Program, Pfizer